ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price was up 16.1% during trading on Thursday . The company traded as high as $1.9269 and last traded at $1.87. Approximately 1,129,981 shares changed hands during trading, an increase of 5,459% from the average daily volume of 20,327 shares. The stock had previously closed at $1.61.
ImmunoPrecise Antibodies Stock Up 1.8%
The company has a fifty day moving average price of $1.92 and a two-hundred day moving average price of $1.47.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Featured Stories
- Five stocks we like better than ImmunoPrecise Antibodies
- How to Calculate Stock Profit
- Rivian’s Chart Says Go, But Some Analysts Still Say No
- What is the Australian Securities Exchange (ASX)
- e.l.f. Sell-Off Is a Good Time to Buy, According to Analysts
- Utilities Stocks Explained – How and Why to Invest in Utilities
- T-Mobile Is The Most Oversold Mega-Cap Stock—Time to Buy?
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
